Page last updated: 2024-09-04

abt 491 and Anaphylaxis

abt 491 has been researched along with Anaphylaxis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Collange, O; Garvey, LH; Geny, B; Mertes, PM; Nicoll, S; Oulehri, W; Tacquard, C; Tuzin, N	1

Other Studies

1 other study(ies) available for abt 491 and Anaphylaxis

Article	Year
Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2020, Volume: 50, Issue:3 Topics: Anaphylaxis; Animals; Disease Models, Animal; Epinephrine; Hemodynamics; Imidazoles; Indoles; Platelet Membrane Glycoproteins; Rats; Receptors, G-Protein-Coupled	2020

Article

Year

Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2020, Volume: 50, Issue:3

Topics: Anaphylaxis; Animals; Disease Models, Animal; Epinephrine; Hemodynamics; Imidazoles; Indoles; Platelet Membrane Glycoproteins; Rats; Receptors, G-Protein-Coupled

2020